Henssen et al. found that MYCN-amplified neuroblastoma cell lines were more sensitive to OTX015 treatment than those MYCN non-amplification NB cells in their MYCN-driven neuroblastoma xenograft model (Henssen et al., 2016). This evidence concerns the gene MYCN and neuroblastoma.